For Prescribing Information and Boxed Warning, see https://bit.ly/3StGv1T. BOTOX? Cosmetic Day is here! Celebrate by sharpening your skills with all-new training available at AMIOnline. AMI is always ready to enhance your education. See the link in bio! BOTOX? Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: - Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity - Moderate to severe lateral canthal lines associated with orbicularis oculi activity - Moderate to severe forehead lines associated with frontalis activity - Moderate to severe platysma bands associated with platysma muscle activity IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX? Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses. Please see in the video additional Important Safety Information. Like, save, and share this post. Never miss an AMI post: enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #BotoxCosmetic #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #Injector This post is intended for U.S. audiences.
关于我们
Where world-class faculty deliver cutting-edge, proprietary aesthetics education to help take you to the next level. For U.S. audiences. Review our LinkedIn community guidelines at https://bit.ly/AbbvieSocialGuidelines
- 网站
-
amionline.com
Allergan Medical Institute的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
动态
-
At AMI, we foster clinical excellence through a broad range of best-in-class education that empowers our practitioners to deliver desired results for patients. Have you learned with us lately? Visit AMIOnline.com to explore our extensive educational offerings. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysiciansAssistant #FacialAesthetics #Injector #AestheticBusiness #AestheticMarketing #AestheticPractice #AMIforBusinessEducation This post is intended for U.S. audiences.
-
For Prescribing Information and Boxed Warning, see https://bit.ly/3StGv1T. View the latest AMI Live Webcast on demand at AMIOnline.com—plus a special, post-webcast Q&A. In this video, 3 experts highlight the history of BOTOX? Cosmetic, patient assessment and retention, and perform a live injection. Now available on demand at AMIOnline.com. BOTOX? Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: - Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity - Moderate to severe lateral canthal lines associated with orbicularis oculi activity - Moderate to severe forehead lines associated with frontalis activity IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX? Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses. Please see additional Important Safety Information in the video. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #EmpoweringExcellenceInAesthetics #AMIempoweringexcellence #TrainedByAMI #AestheticEducation #FacialInjectables #BotoxCosmetic #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysiciansAssistant #Injector This post is intended for U.S. audiences.
-
Ready for the next MD Codes? program? Good news—there is an exclusive and limited virtual opportunity to experience this exciting upcoming event, led by world-renowned injector and founder of the MD Codes?, Dr Maurício de Maio.* In this comprehensive program, you’ll learn the principles of this systematic approach designed to achieve desired results consistently. The MD Codes??, unique assessment skills, treatment planning, and injection technique. To tune in to the livestream program on November 16, register at https://lnkd.in/gNi4mgAK. *Maurício de Maio is a medical doctor (CRM/SP 69331) and board-certified surgeon (RQE 14478). Please see Indications and Important Safety Information for JUVéDERM? Collection of Fillers in this video. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #TempleTrained #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #CosmeticInjector #Injector @mauriciodemaio This post is intended for U.S. audiences.
-
For Prescribing Information and Boxed Warning, see https://bit.ly/3StGv1T. BOTOX? Cosmetic is FDA approved for 3 areas - for treating moderate to severe glabellar lines, lateral canthal lines, and forehead lines. BOTOX? Cosmetic’s 4th FDA approved indication temporarily improves the appearance of moderate to severe platysma bands in adults.2 - BOTOX? Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: - Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity - Moderate to severe lateral canthal lines associated with orbicularis oculi activity - Moderate to severe forehead lines associated with frontalis activity - Moderate to severe platysma bands associated with platysma muscle activity IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX? Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses. Please see in the video additional Important Safety Information. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #EmpoweringExcellenceInAesthetics #AMIEmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #FacialInjectables #BotoxCosmetic #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysiciansAssistant #FacialAesthetics #Injector This post is intended for U.S. audiences.
-
At the latest AMI Speaker Training, our faculty were temple-trained on the newest indication for JUVéDERM? VOLUMA? XC, the only product FDA approved to treat moderate to severe temple hollowing. Presentations, workshops, and live injection demonstrations provided a complete educational experience. AMI Faculty are now ready to educate and train on the new indication with injectors nationwide. Watch the highlights here. Please see Indications and Important Safety Information for JUVéDERM? VOLUMA? XC in this video. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #TempleTrained #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #CosmeticInjector #Injector #JuvedermVoluma This post is intended for U.S. audiences.
-
For Prescribing Information and Boxed Warning, see https://bit.ly/3StGv1T. BOTOX? Cosmetic Day is coming soon! Celebrate by sharpening your skills with all-new training available at AMIOnline. AMI is always ready to enhance your education. See the link in bio! BOTOX? Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: - Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity - Moderate to severe lateral canthal lines associated with orbicularis oculi activity - Moderate to severe forehead lines associated with frontalis activity IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX? Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses. Please see in the video additional Important Safety Information. Like, save, and share this post. Never miss an AMI post: enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #BotoxCosmetic #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #Injector This post is intended for U.S. audiences.
-
Don’t miss the next AMI Live Webcast, “Winning Consultation Strategies to Elevate Aesthetic Outcomes,” on Friday, October 11 at 9 AM PT/12 PM ET. You’ll gain key insights into today’s filler patients and learn advanced injection techniques to meet their needs. Register today at the AMILiveWebcasts.com. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysiciansAssistant #FacialAesthetics #CosmeticInjector #Injector This post is intended for U.S. audiences.
Winning Consultation Strategies to Elevate Aesthetic Outcomes
-
That’s a wrap on an incredible AMI speaker training! Our top faculty learned about the exciting new JUVéDERM? VOLUMA? XC indication to improve moderate to severe temple hollowing with 2 days of immersive, comprehensive education. These experts are ready to train aesthetic injectors across the country on these insights! Swipe right for Indications and Important Safety Information for JUVéDERM? VOLUMA? XC. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #TempleTrained #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #CosmeticInjector #Injector #JuvedermVoluma This post is intended for U.S. audiences.
-
AMI is taking on San Diego for another speaker training session! JUVéDERM? VOLUMA? XC is now approved to improve moderate to severe temple hollowing in adults over the age of 21. AMI is leading the way in aesthetics education, one indication at a time! Stay tuned tomorrow for all things temple! Swipe right for Indications and Important Safety Information for JUVéDERM? VOLUMA? XC. Like, save, and share this post. Never miss an AMI post: Enable notifications by clicking the bell icon at the top of our profile. #AllerganMedicalInstitute #AMIempoweringexcellence #EmpoweringExcellenceInAesthetics #TrainedByAMI #AestheticEducation #TempleTrained #FacialInjectables #PlasticSurgeon #AestheticDoctor #AestheticDermatology #AestheticNP #AestheticNurse #PhysicianAssistant #FacialAesthetics #CosmeticInjector #Injector #JuvedermVoluma This post is intended for U.S. audiences.